RPRX
NASDAQ · Pharmaceuticals
Royalty Pharma Plc- Cl A
$45.57
-0.04 (-0.09%)
Performance
1D
—
1W
—
1M
—
3M
+16.19%
6M
+30.05%
1Y
+34.98%
YTD
+17.27%
Open$45.24
Previous Close$45.61
Day High$45.90
Day Low$45.15
52W High$47.86
52W Low$29.66
Volume—
Avg Volume3.56M
Market Cap26.35B
P/E Ratio34.18
EPS$1.37
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$40.77
Above
SMA 200
$37.28
Above
RSI (14)
85.1
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-20.4% upside
Current
$45.57
$45.57
Target
$36.26
$36.26
$26.65
$36.26 avg
$40.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.45B | 2.40B | 6.69B |
| Net Income | 792.62M | 698.96M | 946.13M |
| Profit Margin | 32.4% | 30.8% | 14.1% |
| EBITDA | 1.59B | 1.48B | 1.13B |
| Free Cash Flow | — | — | 700.09M |
| Rev Growth | +2.1% | +2.1% | +2.6% |
| Debt/Equity | 1.38 | 1.38 | 0.41 |
Dividend
Dividend Yield2.06%
Annual Dividend$0.65
Payout Ratio49.1%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |